CUTR - Cutera Inc. Debt to Book Capitalization Ratio

Corporate company logo of Cutera, Inc. (CUTR)

Regular sales of laser consumables provide a steady profit stream for Cutera, Inc. (CUTR). The company's total debt-to-equity ratio reflects borrowing dynamics, where the 0.00 metric serves as the target level. Strong confidence among medical professionals in Face + Body systems strengthens the brand's position, although demand for equipment remains cyclical and dependent on consumer spending on cosmetology.

Cutera, Inc. - CUTR Debts to Book Capitalization (period 07/04/2022 - 03/22/2025)
Flagship merchandise of Cutera Inc

Competition in the aesthetic medicine sector and the limited pricing power of Cutera, Inc. (CUTR) necessitate strict control over financial stability. This indicator measures the ratio of total liabilities to equity on the balance sheet, determining the business's degree of dependence on borrowed funds. The metric allows for an assessment of default risk and the capital cushion in the event of falling sales. It is critical for investors to monitor the balance between debt load and growth potential. This chart of the debt-to-equity structure objectifies this data based on session closing prices.

Competitors of Cutera, Inc.

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Novanta (NOVT)|HAE - Debt to Net Assets Ratio|INSP: Debts to Book Capitalization|PRCT (Procept) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation CNMD|Debts to Book Capitalization Ratio pulsebiosciences.com|InMode - Debts to Book Capitalization|Debts to Book Value Picard Medical Corp PMI|Debt to Book Value SRDX (Surmodics Corp)|SENS - Debts to Book Capitalization|Debt to Book Value NeuroPace, Inc. NPCE|TCMD - Debt to Book Capital|SANUWAVE - Debts to Book Capitalization|Outset Medical Inc (OM) - Debts to Net Assets|Debts to Book Capitalization ELMD|Debt to Book Value LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Debt to Book Value|Debt to Net Assets Ratio PROF (profoundmedical.com)|Baird Medical - Debt to Book Capitalization Ratio|Debt to Book Value EDAP TMS SA EDAP|APYX (Bovie Medical) - Debts to Book Capitalization|ICCM - Debts to Book Value|Debts to Book Capitalization pulmonx.com|TELA Bio (TELA) - Debt to Book Value Ratio|CTSO: Debts to Book Capitalization|Debts to Net Assets Sensus Healthcare Inc|Debts to Book Capitalization ZYXI (Zynex Inc)|Debt to Book Value electrocore.com (ECOR)|Debts to Book Capitalization RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Debts to Book Capitalization|ICU - Debt to Book Capitalization Ratio|IRIDEX Corporation (IRIX) - Debt to Book Capitalization Ratio|Debt to Book Value ibs.inc INBS|Beyond Air (XAIR) - Debt to Net Assets Ratio|Debts to Book Capitalization PFSA (Profusa Inc)|Debts to Book Value SSKN|GCTK: Debt to Book Capitalization Ratio|Debt to Net Assets NanoVibronix Inc. NAOV|Debt to Book Value VERO (Venus Concept Corp)|Debts to Book Capitalization Nuwellis Corp NUWE|Debts to Book Capitalization AEMD (Aethlon Medical)|ASXC: Debts to Net Assets|Debt to Book Capitalization Ratio Avinger (AVGR)|BSGM (biosig.com) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio